Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Renowned Wound Healing and Herbal Skincare products company Dermozone opens office in Chennai - The Pharma Times | Pharma & Health Care News Portal

Renowned Wound Healing and Herbal Skincare products company Dermozone opens office in Chennai

Bengaluru, March 10, 2016: Dermozone, a global wound healing and Herbal Skincare Products Company, announced that it has set up office in Chennai, it’s second in India after Bengaluru. The Chennai office, located at Annasalai ,would be an extension of the company’s existing Bengaluru office and also be the operations hub for Dermozone in India .

Dermozone, with headquarters in Jakarta, Indonesia had in the last quarter of 2015 announced its entry into the Indian market, by setting up an office in Bengaluru in the name of Indo- Dermozone Herbal Pvt. Ltd. Dermozone also has operations in UK, USA, Japan, Russia, Seoul, China, Taiwan, Hong Kong, South Africa, Brazil, Argentina, Mexico, Chile, Australia and Dubai (Middle East).

“We are extremely pleased to announce the opening of our Chennai office and would be very soon unveiling in India our renowned herbal Skincare products under our two brands -‘MedCare’ and ‘BodyCare’.” SAID MR. K.S. DHARSHAN, CHAIRMAN & CEO OF DERMOZONE.“ ‘MedCare’ brand comprises of four products- WOUNDCARE (wound and burn), VAGINYCARE (feminine usage), BABYCARE (allergies, rashes etc) and MEDCARE SOAP. ‘BodyCare’ caters to the cosmetics and beauty care market with a range of seventeen products.”

“Dermozone had recently announced that it had developed ‘dalethyne ‘, a revolutionary chemical molecule compound, proven as an antimicrobial agent against most of the bacteria, fungi and yeasts. Dermozone’s best kept secret, ‘dalethyne ‘will be the key ingredient in the company’s MedCare and BodyCare range of herbal products soon to be launched in India.” SAID MR. MANJUNATHA K.G ,CHIEF OPERATION OFFICER OF INDO- DERMOZONE HERBAL PVT. LTD. “Currently, Dermozone’s MedCare product ‘WoundCare’ is under clinical trial at Apollo Hospitals, Chennai and expected to be completed by the second quarter of 2016.”

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

6 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

1 week ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

3 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago